HIGHLIGHTS
- who: Renfeng Xu et al. from the Provincial University Key Laboratory of Sport and Health Science, School of Physical Education and Sport have published the research: Action Sites and Clinical Application of HIF-1 Inhibitors, in the Journal: Molecules 2022, 3426 of /2022/
- what: Together, as an important transcription factor under hypoxia, HIF-1u03b1 regulates angiogenesis, glucose metabolism, apoptosis, and autophagy, and also participates in the regulation of multiple signaling pathways, playing an important role during the growth and development of the body, and in various physiological and pathological processes.
- future: The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.